These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17601364)

  • 1. Penetration of garenoxacin into lung tissues and bone in subjects undergoing lung biopsy or resection.
    Krishna G; Gotfried MH; Rolston K; Wang Z
    Curr Med Res Opin; 2007 Aug; 23(8):1841-7. PubMed ID: 17601364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of omeprazole on the bioavailability and safety of garenoxacin in healthy volunteers.
    Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z
    J Clin Pharmacol; 2007 May; 47(5):628-32. PubMed ID: 17395892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.
    Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z
    Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Garenoxacin pharmacokinetics in subjects with renal impairment.
    Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z
    Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue and fluid penetration of garenoxacin in surgical patients.
    Edmiston CE; Krepel CJ; Seabrook GR; Towne JB; Smith TL; Loehrl TA; Wackym PA; Johnson CP; Otterson MF; Gajjar DA; Krishna G
    Surg Infect (Larchmt); 2007 Apr; 8(2):179-88. PubMed ID: 17437363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.
    Kastner M; Rahm U; Baumann-Wilschke I; Bello A; Stahlmann R
    Arch Toxicol; 2004 Feb; 78(2):61-7. PubMed ID: 14661070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of levofloxacin into lung tissue after oral administration to subjects undergoing lung biopsy or lobectomy.
    Lee LJ; Sha X; Gotfried MH; Howard JR; Dix RK; Fish DN
    Pharmacotherapy; 1998; 18(1):35-41. PubMed ID: 9469679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
    Torkildsen G; O'Brien TP
    Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.
    Wang Z; Grasela DM; Krishna G
    Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the penetration of garenoxacin into the breast milk of lactating women.
    Amsden GW; Nicolau DP; Whitaker AM; Maglio D; Bello A; Russo R; Barros A; Gajjar DA
    J Clin Pharmacol; 2004 Feb; 44(2):188-92. PubMed ID: 14747428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion of ertapenem into bone and synovial tissues.
    Boselli E; Breilh D; Djabarouti S; Bel JC; Saux MC; Allaouchiche B
    J Antimicrob Chemother; 2007 Oct; 60(4):893-6. PubMed ID: 17704514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
    Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
    J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical studies of garenoxacin.
    Takagi H; Tanaka K; Tsuda H; Kobayashi H
    Int J Antimicrob Agents; 2008 Dec; 32(6):468-74. PubMed ID: 18790608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.
    Rodvold KA; Gotfried MH; Cwik M; Korth-Bradley JM; Dukart G; Ellis-Grosse EJ
    J Antimicrob Chemother; 2006 Dec; 58(6):1221-9. PubMed ID: 17012300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone bone penetration in patients with septic non-union of the tibia.
    Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G
    Int J Infect Dis; 2011 Jun; 15(6):e415-21. PubMed ID: 21497532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE; Golden JA; McIver M; Little E; Zurlinden E
    Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients.
    Esposito S; Noviello S; D'Errico G; Motta G; Passali D; Aimoni C; Pilucchi S; Fallani S; Cassetta MI; Mazzei T; Novelli A
    J Antimicrob Chemother; 2006 Apr; 57(4):789-92. PubMed ID: 16504997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.